Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

GRP78-mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells.

Dauer P, Sharma NS, Gupta VK, Nomura A, Dudeja V, Saluja A, Banerjee S.

Mol Oncol. 2018 Sep;12(9):1498-1512. doi: 10.1002/1878-0261.12322. Epub 2018 Aug 7.

2.

Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.

Dauer P, Zhao X, Gupta VK, Sharma N, Kesh K, Gnamlin P, Dudeja V, Vickers SM, Banerjee S, Saluja A.

Cancer Res. 2018 Mar 1;78(5):1321-1333. doi: 10.1158/0008-5472.CAN-17-2320. Epub 2017 Dec 19.

3.

NFκB-Mediated Invasiveness in CD133+ Pancreatic TICs Is Regulated by Autocrine and Paracrine Activation of IL1 Signaling.

Nomura A, Gupta VK, Dauer P, Sharma NS, Dudeja V, Merchant N, Saluja AK, Banerjee S.

Mol Cancer Res. 2018 Jan;16(1):162-172. doi: 10.1158/1541-7786.MCR-17-0221. Epub 2017 Sep 28.

PMID:
28970361
4.

Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer.

McGinn O, Gupta VK, Dauer P, Arora N, Sharma N, Nomura A, Dudeja V, Saluja A, Banerjee S.

Sci Rep. 2017 Aug 11;7(1):7872. doi: 10.1038/s41598-017-08447-3.

5.

Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer.

Dauer P, Gupta VK, McGinn O, Nomura A, Sharma NS, Arora N, Giri B, Dudeja V, Saluja AK, Banerjee S.

Sci Rep. 2017 May 8;7(1):1564. doi: 10.1038/s41598-017-01696-2.

6.

Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.

Arora N, Alsaied O, Dauer P, Majumder K, Modi S, Giri B, Dudeja V, Banerjee S, Von Hoff D, Saluja A.

PLoS One. 2017 Feb 13;12(2):e0171827. doi: 10.1371/journal.pone.0171827. eCollection 2017.

7.

Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters.

Dauer P, Nomura A, Saluja A, Banerjee S.

Pancreatology. 2017 Jan - Feb;17(1):7-12. doi: 10.1016/j.pan.2016.12.010. Epub 2016 Dec 23. Review.

8.

Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer.

Nomura A, Majumder K, Giri B, Dauer P, Dudeja V, Roy S, Banerjee S, Saluja AK.

Lab Invest. 2016 Dec;96(12):1268-1278. doi: 10.1038/labinvest.2016.109. Epub 2016 Oct 24.

9.

Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133+ tumor initiating cells.

Nomura A, Dauer P, Gupta V, McGinn O, Arora N, Majumdar K, Uhlrich C 3rd, Dalluge J, Dudeja V, Saluja A, Banerjee S.

Oncotarget. 2016 Aug 30;7(35):56324-56337. doi: 10.18632/oncotarget.10838.

10.

Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation.

Banerjee S, Sindberg G, Wang F, Meng J, Sharma U, Zhang L, Dauer P, Chen C, Dalluge J, Johnson T, Roy S.

Mucosal Immunol. 2016 Nov;9(6):1418-1428. doi: 10.1038/mi.2016.9. Epub 2016 Feb 24.

Supplemental Content

Support Center